
Translational Research and
Therapeutic Development
Samuel C.
Fehling, PhD
Drug Discovery & Development
- Small-Molecule & Antibody Discovery
- Target Identification & Validation
- IND-Enabling Study Support
Pharmacology & Assay Development
- Pharmacodynamic (PD) Assay Design
- In Vitro & In Vivo Screening
- Mechanism of Action (MOA) Studies
Specialized Analytics
- Antibody Characterization (SPR/Biacore)
- High-Throughput Screening (Gyrolab)
- Molecular Diagnostics (PCR Platforms)
About Sam
I am a translational scientist with a PhD in Biomedical Sciences (Cancer Biology) and deep expertise in preclinical pharmacology, target validation, and translational biomarker development across small-molecule and antibody programs. Experienced in collaborating across chemistry, biology, in-life, and clinical / non-clinical teams to support IND-enabling studies.
Work Experience
BioCryst Pharmaceuticals, Inc.
Sr. Research Biologist
• July 2025 – October 2026
Focus: Biologics and Pharmacodynamics
Lead Assay Qualification
Developed and qualified high-sensitivity PD assays (Gyrolab) to quantify therapeutic protein levels in NHP models.
Biologics Characterization
Utilized SPR (Biacore T200) to provide critical binding kinetics and cross-reactivity data for candidate selection.
Regulatory Support
Generated comprehensive analytical data and documentation packages to support IND-enabling studies.
Research Biologist
• December 2022 – July 2025
Focus: High-Throughput Screening and Biomarkers
Cross-Modality Screening
Executed high-throughput in vitro screening for both small-molecule and antibody-based therapeutic pipelines.
Biomarker Evaluation
Characterized therapeutic activity and safety through the analysis of rodent and NHP plasma samples.
BioGX, Inc.
Research & Development Scientist
• February 2020 – December 2022
Focus: Molecular Diagnostics and Validation
Diagnostic Development
Developed and qualified multiple PCR-based molecular diagnostic assays for FDA Emergency Use Authorization (EUA).
Quality & Compliance
Managed IQ/OQ/PQ qualifications and QC risk assessments to ensure manufacturing and regulatory readiness.
University of Alabama at Birmingham
Graduate Research Assistant
• August 2014 – December 2019
Focus: Translational Oncology and Disease Modeling
Cancer Research
Investigated drug resistance mechanisms and identified synergistic therapeutic combinations in cholangiocarcinoma and PDAC models.
Complex Modeling
Utilized Patient-Derived Xenograft (PDX) and in vivo mouse models to evaluate therapeutic efficacy and biomarker response.
Technical Skills

Murine Mouse Models
Experienced with athymic nude & C57BL/6 mice, oral gavage, intraperitoneal (IP) injection and patient-derived xenograft (PDX) models.

In Vitro / Primary Cell Culture
Utilizing commercially available cell culture lines & developing primary cell culture lines from patient tumors.

Polymerase Chain Reaction (PCR)
Qualified in PCR platforms including BD MAX, Thermo Fisher QuantStudio, Bio-Rad CFX, ABI 7500, SmartCycler and BioGX Pixl.
Laboratory Techniques
- ELISA
- Western Blotting
- PCR and qPCR
- Surface Plasmon Resonance (SPR)
- Antibody Screening
- Target Validation
Preclinical Research
- Cell Culture (Immortalized and Primary)
- Patient-Derived Xenograft (PDX) Models
- Murine Xenograft Models
- Pharmacodynamic (PD) Studies
Instrumentation
- Gyrolab xPlore
- Biacore T200
- Bio-Rad CFX96 / 364
- Thermo Fisher QuantStudio
- ABI 7500
Scientific Software
- GraphPad Prism
- Biacore Evaluation Software
- Gyrolab Evaluator
- ImageJ (FIJI)
- Microsoft 365
Creative Projects

Computers & Technology
Self-hosted website infrastructure, Linux systems administration, Docker environments, networking and automation projects demonstrating technical problem-solving outside the laboratory. This website is self-hosted on my personal Raspberry Pi 4.

DJI & First-Person View (FPV) Drones
Pilot skilled in operating DJI drones for photography / videography & FPV drones for acrobatics / stunts. Competent in ad-hoc electronic repairs such as wiring & soldering.

Photography & Photo Editing
Photographer with expertise in Adobe Photoshop and Lightroom, adept in mirrorless, smartphone and drone photography with over 110 stock photos sold through Shutterstock & Getty.
Education
University of Alabama at Birmingham (UAB)
Ph.D. in Biomedical Sciences (Cancer Biology)
2014 – 2019
- Cancer Biology Newsletter Editorial Board
- Cancer Biology Student Seminar Co-Organizer
- Graduate Career Awareness and Trends (GCAT) Communications Director
University of Wisconsin – Eau Claire (UWEC)
B.S. in Biochemistry & Molecular Biology
2010 – 2014
- Biology Club Treasurer
- Molecular Movement Treasurer
Publications
11 Peer-Reviewed Articles with 420+ Citations
Featured Publications
BET Inhibition Decreases HMGCS2 and Sensitizes Resistant Pancreatic Tumors to Gemcitabine
Aubrey L Miller, Samuel C Fehling, Rebecca B Vance, Dongquan Chen, Eric Josh Brown, M Iqbal Hossain, Eric O Heard, Shaida Andrabi, Hengbin Wang, Eddy S Yang, Donald J Buchsbaum, Robert CAM van Waardenburg, Susan L Bellis, Karina J Yoon.
Cancer Letters. 2024 June 28. (PMID: 38704133)
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
Aubrey L. Miller, Patrick L. Garcia, Samuel C. Fehling, Tracy L. Gamblin, Rebecca B. Vance, Leona N. Council, Dongquan Chen, Eddy S. Yang, Robert CAM van Waardenburg, Karina J. Yoon.
Cancers. 2021 July 11. (PMCID: PMC8303731)
The Combination of BET and PARP Inhibitors is Synergistic in Models of Cholangiocarcinoma
Samuel C. Fehling, Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, Karina J. Yoon.
Cancer Letters. 2019 October 9. (PMCID: PMC7017643)
The BET Inhibitor JQ1 Attenuates Double Strand Break Repair and Sensitizes Models of Pancreatic Ductal Adenocarcinoma to PARP Inhibitors
Miller AL, Fehling SC, Garcia PL, Gamblin TL, Council LN, van Waardenburg RCAM, Yang ES, Bradner JE, Yoon KJ.
EBioMedicine. 2019 June. (PMCID: PMC6604668)
FTY720 Enhances the Anti-Tumor Activity of Carboplatin and Tamoxifen in a Patient-Derived Xenograft Model of Ovarian Cancer
Kreitzburg KM, Fehling SC, Landen CN, Gamblin TL, Vance RB, Arend RC, Katre AA, Oliver PG, van Waardenburg RCAM, Alvarez RD, Yoon KJ.
Cancer Letters. 2018 August 15(18): 30527-5. (PMCID: PMC6756795)
MicroRNA-31 is Required for Astrocyte Specification
Meares GP, Rajbhandari R, Gerigk M, Tien CL, Chang C, Fehling SC, Rowse A, Mulhern KC, Nair S, Gray GK, Berbari NF, Bredel M, Benveniste EN, Nozell SE.
Glia. 2018 May, 66(5): 987-998. (PMCID: PMC5851835)
A Comparative Study of All-atom Molecular Dynamics Simulation…
Fehling SC, Strom AM, Lehman BP, Andrews RJ, Bhattacharyya S, Hati S.
American Journal of Undergraduate Research. 2017 June; 14(2): 27-44 (DOI: 10.33697/AJUR.2017.012)
Loss of SOCS3 in Myeloid Cells Prolongs Survival in a Syngeneic Model of Glioma
McFarland BC, Marks MP, Rowse AL, Fehling SC, Gerigk M, Qin H, Benveniste EN.
Oncotarget. 2016 April 12; 7(15): 20621-35. (PMCID: PMC4991480)
Loss of Tumor Suppressive microRNA-31 Enhances TRADD/NF-κB Signaling in Glioblastoma
Rajbhandari R, McFarland BC, Patel A, Gerigk M, Gray GK, Fehling SC, Bredel M, Berbari NF, Kim H, Marks MP, Meares GP, Sinha T, Chuang J, Benveniste EN, Nozell SE.
Oncotarget. 2015 July 10; 6(19): 17805-16. (PMCID: PMC4627347)
Comparison of Intrinsic Dynamics of Cytochrome p450 Proteins Using Normal Mode Analysis
Dorner ME, McMunn RD, Bartholow TG, Calhoon BE, Conlon MR, Dulli JM, Fehling SC, Fisher CR, Hodgson SW, Keenan SW, Kruger AN, Mabin JW, Mazula DL, Monte CA, Olthafer AG, Sexton AE, Soderholm BR, Strom AM, Hati S.
Protein Science. 2015 September; 24(9): 1495-507. (PMCID: PMC4570543)
Probing the Global and Local Dynamics of Aminoacyl-tRNA Synthetases using All-Atom and Coarse-Grained Simulations
Strom AM, Fehling SC, Bhattacharyya S, Hati S.
Journal of Molecular Modeling. 2014 May; 20(5): 2245 (PMCID: PMC4030129)
Contact
LinkedIn • Google Scholar • GitHub • ORCID • ResearchGate
Open to Scientist, Senior Scientist, Principal Scientist and Translational Research opportunities in oncology, immunology and drug discovery.
Open to relocation.
Email: [email protected]
Outside the Lab
I Love Exploring Our National Parks and Road Tripping Across the Country. Full Stories Can Be Found On Our Travel Blog, With Each Mile











